Are there specific patient populations where weight-based dosing of pembrolizumab is preferred over fixed dosing?
No direct evidence was identified for specific patient populations where weight-based dosing of pembrolizumab is preferred over fixed dosing, although economic factors may favor weight-based dosing in certain cases.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-10
- DOI
- https://doi.org/10.5281/zenodo.24120890
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00